ARTICLE | Company News
Boehringer, Zealand in diabetes, obesity deal
June 17, 2011 12:31 AM UTC
Zealand Pharma A/S (CSE:ZEAL) granted Boehringer Ingelheim GmbH (Ingelheim, Germany) exclusive, worldwide rights to dual agonists of glucagon receptor (GCGR) and glucagon-like peptide-1 receptor ( GLP...